# A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated

> **NCT00233506** · PHASE1 · COMPLETED · sponsor: **University of Iowa** · enrollment: 41 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** CpG 7909

## Key facts

- **NCT ID:** NCT00233506
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233506, "A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00233506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*